HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$0.82
Day range
$0.79 - $0.82
Year range
$0.52 - $1.14
Market cap
59.81M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.60M | -3.15% |
Net income | -21.55M | 11.36% |
Net profit margin | — | — |
Earnings per share | -0.28 | 18.99% |
EBITDA | -21.64M | 18.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 164.18M | -30.60% |
Total assets | 179.92M | -31.69% |
Total liabilities | 29.24M | -6.00% |
Total equity | 150.68M | — |
Shares outstanding | 72.96M | — |
Price to book | 0.39 | — |
Return on assets | -28.89% | — |
Return on capital | -30.79% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -21.55M | 11.36% |
Cash from operations | -17.03M | 21.15% |
Cash from investing | 12.22M | -7.48% |
Cash from financing | 56.00K | -85.34% |
Net change in cash | -4.76M | 40.70% |
Free cash flow | -8.24M | 38.47% |
About
Founded
2015
Headquarters
Website
Employees
58